ARWR NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Arrowhead Pharmaceuticals Inc · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 84.65 USD
-1.1% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 20.4% above the Trend Line and sits at 86.5% of its 52-week range. The latest completed week returned -1.1%, after a 0.8% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers. Options positioning is mixed with 37/100 conviction, while the latest news-sentiment score is 59/100. Near-term considerations: volume confirmation is below normal; earnings are due in 2d.

Setup score 65 out of 100
Latest Close 84.65 USD 31 Jul 2026
1W Return -1.1% latest completed week
4W Return 0.8% short-term follow-through
12W Return 16.5% quarterly tape
Trend Breadth 96.2% 50 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
What is working
  • The trend backdrop is active with a 50-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 16 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -1.1% Latest completed week; four-week move 0.8%. Indicator stack 98/46 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 55.68% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Mixed 37/100 conviction; expected move 12.5%. News sentiment 59/100 65 relevant articles in the latest sentiment read. Event risk 2d Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 20.4% above the Trend Line and sits at 86.5% of its 52-week range. The latest completed week returned -1.1%, after a 0.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8812-week average 0.76

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.88Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers1616 reversal markers

No recent accumulation markers. 16 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 0.8% over four weeks, 16.5% over 12 weeks, and 431.4% over one year. The current trend has remained active for 50 consecutive weeks.

Performance by holding period

1W-1.1%
4W0.8%
12W16.5%
26W22.1%
52W431.4%
Active trend streak50 weeks
Active weeks in one year50
Trend breadth96.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.13Latest activity-pressure read.
Pressure change-82.5%Four-week change in activity pressure.
Leadership36.11Latest relative-leadership reading.
RS change-11.0%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength24/100Blend of value, momentum, and quality. Underlying universe rank 77; rank 1 is best.
Value13/100Relative valuation strength. Underlying universe rank 88; rank 1 is best.
Quality26/100Profitability and accounting quality. Underlying universe rank 75; rank 1 is best.
Momentum100/100Medium-term price momentum. Underlying universe rank 1; rank 1 is best.
Growth69/100Revenue and earnings growth. Underlying universe rank 32; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
19.4x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-0.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
100.0%
Gross profit retained from each unit of revenue.
Operating margin
-25.7%
Operating profit retained from revenue.
Free-cash-flow margin
-3.5%
Free cash flow generated from revenue.
Return on invested capital
-6.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
9.4%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-119.3%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.4%
Net share repurchases relative to market value.
Shareholder yield
-0.4%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-8.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

ARWR shows mixed options pressure with a 37/100 conviction score, put-call volume ratio of 1.20, expected move of 12.5%, and Sharemaestro trend signal active.

Conviction37/100
Expected move12.5%
Put/call volume1.20
Pressure-5
Speculation14
Volatility86
Trend agreement88
Open options detail
Insider activity1 / 5

1 acquisitions and 5 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment59/100

Weighted news tone is neutral across 65 relevant articles.

29 positive · 32 neutral · 4 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings2dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
Options expected move12.5%Nearest-chain priced movement where available.
52-week drawdown-11.4%Distance below the 52-week high.
13-week volatility6.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+15.2%Week of 24 Jul.
Worst week-9.0%Week of 10 Jul.
Latest week-1.1%Week of 31 Jul.

Shape of recent returns

Strong gains8
Modest gains5
Flat weeks0
Modest losses8
Sharp losses5
Recent vol6.5%13-week weekly-return volatility.
Base vol8.5%52-week weekly-return volatility.
Up/down split32/20Count of positive and negative weeks in the 52-week window.
Average skew8.1% / -3.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape68/100

Trend, activity pressure, participation, and risk combine to a 68/100 tape read.

 Indicator analysis81/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.

Activity pressure 0.88; 16 reversal markers Next-Week ExpectancyPositive 55.68%

Next-week expectancy is positive with a 55.68% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors37/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 75; Small Cap Core rank 91 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options57/100

ARWR shows mixed options pressure with a 37/100 conviction score, put-call volume ratio of 1.20, expected move of 12.5%, and Sharemaestro trend signal active.

Mixed · Options-market disagreement · Expected move 12.5% Sentiment59/100

Weighted news tone is neutral across 65 relevant articles.

Vanguard unit discloses 6.38M Arrowhead (ARWR) shares, a 4.53% stake Insiders1 / 5

1 acquisitions and 5 disposals in the latest 180-day insider tape.

 Earnings2d

Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202684.65 USD-1.1%70.29 USD34.68 USD0.1336.119.0MOn
24 Jul 202685.60 USD15.2%69.73 USD34.34 USD0.3141.2315.3MOn
17 Jul 202674.30 USD-2.7%69.22 USD34.01 USD0.4223.2312.3MOn
10 Jul 202676.40 USD-9.0%69.01 USD33.77 USD0.7123.5410.4MOn
3 Jul 202683.99 USD6.5%68.80 USD33.50 USD0.7240.578.1MOn
26 Jun 202678.89 USD-3.6%68.05 USD33.18 USD0.5535.9026.3MOn
19 Jun 202681.82 USD9.8%67.18 USD32.90 USD0.3737.249.0MOn
12 Jun 202674.52 USD2.0%65.80 USD32.60 USD0.2430.886.7MOn
5 Jun 202673.09 USD-6.2%64.69 USD32.35 USD0.3233.728.1MOn
29 May 202677.91 USD3.9%63.56 USD32.11 USD0.3038.595.4MOn
22 May 202674.95 USD-2.2%62.38 USD31.84 USD0.2439.818.2MOn
15 May 202676.67 USD5.5%61.15 USD31.57 USD0.2147.609.5MOn
8 May 202672.69 USD-2.8%59.82 USD31.31 USD0.0742.399.5MOn
1 May 202674.81 USD1.2%58.58 USD31.10 USD-0.1357.796.8MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.